| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $7,681,095 ) (Continued on the next page) |
| | 2024 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R35GM118182 | Molecular basis of bioelectronic medicine | 000 | 9 | NIH | 4/18/2024 | $678,375 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R21MH135148 | Tau biomarkers in late-onset psychosis | 000 | 1 | NIH | 1/30/2024 | $209,375 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL162912 | Kids: Nocturnal Investigation into Glomerular Disease, Hypertension, and Transcriptomics (kNIGHT) | 000 | 2 | NIH | 2/9/2024 | $670,919 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01DK131482 | Dissecting the heterogeneity and function of myeloid cells in lupus nephritis | 000 | 2 | NIH | 12/12/2023 | $589,018 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K23DK132459 | Using Digital Solutions to Improve Transition of Care for Patients with Acute Kidney Injury | 000 | 3 | NIH | 2/6/2024 | $192,999 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R13MH132238 | Critical Research Issues in Latinx Mental Health/American Society of Hispanic Psychiatry | 000 | 2 | NIH | 1/22/2024 | $10,000 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R13MH132238 | Critical Research Issues in Latinx Mental Health/American Society of Hispanic Psychiatry | 000 | 2 | NIH | 1/22/2024 | $20,000 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R13MH132238 | Critical Research Issues in Latinx Mental Health/American Society of Hispanic Psychiatry | 001 | 2 | NIH | 1/24/2024 | $10,000 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R13MH132238 | Critical Research Issues in Latinx Mental Health/American Society of Hispanic Psychiatry | 001 | 2 | NIH | 1/24/2024 | $10,000 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R13MH132238 | Critical Research Issues in Latinx Mental Health/American Society of Hispanic Psychiatry | 001 | 2 | NIH | 1/24/2024 | -$20,000 |
| | 2024 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HG011711 | Polygenic Embryo Screening: Towards Informed Decision-Making | 000 | 4 | NIH | 4/8/2024 | $624,888 |
| | 2024 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K23MH127300 | Striatal Function in Psychosis Relapse | 000 | 3 | NIH | 4/22/2024 | $49,743 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH120313 | Relationships between Neuroactive Steroids, GABA and Glutamate MRS and Connectivity of the Default Mode Network in Postpartum Depression | 000 | 5 | NIH | 2/26/2024 | $432,911 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01AI152044 | Role of Toll-like Receptor 9 in Fibroblastic Reticular Cell-based Therapy for Intra-abdominal Sepsis | 000 | 7 | NIH | 2/12/2024 | $383,297 |
| | 2024 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01CA238523 | Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia | 001 | 5 | NIH | 4/17/2024 | $27,544 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01CA238523 | Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia | 000 | 5 | NIH | 11/10/2023 | $495,764 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UM1HL147371 | Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse | 001 | 6 | NIH | 2/23/2024 | $470,622 |
| | 2024 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01CA236591 | Cellular interactions between TGF-beta pathway members and epigenetic regulators in liver and gastrointestinal cancers | 001 | 6 | NIH | 4/5/2024 | $376,875 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH117646 | Cognitive Genomics as a Window on Neurodevelopment and Psychopathology | 001 | 6 | NIH | 1/29/2024 | $586,985 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R35HL171168 | Cellular and Molecular Control of Normal and Disordered Erythropoiesis | 000 | 1 | NIH | 2/6/2024 | $870,543 |
| | 2024 | 2024 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL076179 | Improvement of Organ Function after Severe Hypovolemia | 000 | 15 | NIH | 12/20/2023 | $487,376 |
| | 2024 | 2023 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R21AG082054 | Identifying diagnostic biomarkers for Delirium and predicting cognitive Outcomes in hospitalized older adults using automated Speech Analysis (IDOSA) | 001 | 1 | NIH | 1/12/2024 | $0 |
| | 2024 | 2023 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R21AG082054 | Identifying diagnostic biomarkers for Delirium and predicting cognitive Outcomes in hospitalized older adults using automated Speech Analysis (IDOSA) | 000 | 1 | NIH | 11/17/2023 | $0 |
| | 2024 | 2023 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01NR021134 | Maternal OutcoMes (MOMs) Program: Testing Integrated Maternal Care Model Approaches to Reduce Disparities in Severe Maternal Morbidity | 000 | 1 | NIH | 3/8/2024 | $0 |
| | 2024 | 2023 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UG3OD035513 | Developmental Impact of NICU Exposures (DINE) phase II | 000 | 1 | NIH | 2/12/2024 | $0 |
| | 2024 | 2023 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | OT2OD031915 | The Interdisciplinary Guided Network for Investigation, Translation and Equity (IGNITE) for All of Us Research Program | 000 | 2 | NIH | 3/15/2024 | $0 |
| | 2024 | 2023 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL153810 | Influencing Basic Behavioral Mechanisms of Action while targeting Daily Walking in Those at Risk for Cardiovascular Disease: Science of Behavior Change Factorial Experiment of Behavioral Change | 000 | 3 | NIH | 3/28/2024 | $0 |
| | 2024 | 2023 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R34MH122219 | Refinement and Testing of a New Cognitive-Behavioral Intervention to Treat Executive Dysfunction in College Students with ADHD | 000 | 3 | NIH | 4/2/2024 | $0 |
| | 2024 | 2023 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UM1HL147371 | Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse | 000 | 5 | NIH | 11/14/2023 | $0 |
| | 2024 | 2023 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UM1HL147371 | Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse | 002 | 5 | NIH | 3/6/2024 | $0 |
| | 2024 | 2022 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R03AG070662 | Dysphagia in Hospitalized Persons with Dementia | 000 | 2 | NIH | 3/11/2024 | -$7,010 |
| | 2024 | 2022 | Feinstein Institutes For Medical Research, The | 350 Community Dr | Manhasset | NY | 11030-3816 | NASSAU | USA | U01OH012050 | Assessing the feasibility and acceptability of using non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) to reduce PTSD symptoms in WTC responders | 03 | 2 | CDC | 2/5/2024 | $0 |
| | 2024 | 2022 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R61MH123574 | Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk in Adolescents at Clinical High Risk for Psychosis | 000 | 2 | NIH | 1/19/2024 | $0 |
| | 2024 | 2022 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R03AI156516 | TNF deficiency induces breach of B cell tolerance via altering B cell regulatory signals | 000 | 2 | NIH | 3/12/2024 | $0 |
| | 2024 | 2022 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01NS113893 | Elucidating the Temporality of Structural and Functional Connectivity Changes in Essential Tremor after successful Deep Brain Stimulation to the dentato-rubrothalamic tract | 003 | 4 | NIH | 12/5/2023 | $510,871 |
| | 2024 | 2022 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K08GM132794 | Effects of Memory T Cells on the Response to Cecal Ligation and Puncture | 000 | 4 | NIH | 2/13/2024 | $0 |
| | 2024 | 2022 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | U01CA230690 | Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer | 000 | 6 | NIH | 1/22/2024 | $0 |
| | 2024 | 2022 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K01AR071502 | The role of GLUT3 in the genetics of autoimmunity and immunometabolism | 000 | 5 | NIH | 2/27/2024 | $0 |
| | 2024 | 2022 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01CA236591 | Cellular interactions between TGF-beta pathway members and epigenetic regulators in liver and gastrointestinal cancers | 000 | 5 | NIH | 3/28/2024 | $0 |
| | 2024 | 2022 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH117646 | Cognitive Genomics as a Window on Neurodevelopment and Psychopathology | 000 | 5 | NIH | 1/25/2024 | $0 |
| | 2024 | 2021 | Feinstein Institutes For Medical Research, The | 350 Community Dr | Manhasset | NY | 11030-3816 | NASSAU | USA | U01OH012050 | Assessing the feasibility and acceptability of using non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) to reduce PTSD symptoms in WTC responders | 03 | 2 | CDC | 2/5/2024 | $0 |
| | 2024 | 2021 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R34MH120790 | Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis | 000 | 3 | NIH | 2/6/2024 | $0 |
| | 2024 | 2021 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | U19AI144306 | Etiology and outcome of MIS-C | 000 | 3 | NIH | 12/28/2023 | $0 |
| | 2024 | 2021 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K08AG054727 | Identification of Risk Genes by Comparing Whole Genome Sequences of Alzheimer's Disease Patients and Cognitively Healthy Centenarians | 000 | 5 | NIH | 3/11/2024 | $0 |
| | 2024 | 2020 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R61HD104566 | Evaluating implementation and feasibility of evidence-based universal screening and intervention strategies for firearm injury and mortality prevention among youth and adults in emergency departments | 000 | 1 | NIH | 3/8/2024 | $0 |
| | 2024 | 2020 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R21AG067789 | Evaluation of dopaminergic mechanisms in the DM tau mouse | 000 | 1 | NIH | 10/18/2023 | $0 |
| | 2024 | 2020 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R21MH119616 | Electrical Field and Neuroimaging Based Prediction of ECT Induced Clinical and Cognitive Effects | 000 | 2 | NIH | 12/22/2023 | $0 |
| | 2024 | 2020 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01GM121102 | Orexinergic Modulation of Experimental Sepsis | 000 | 4 | NIH | 3/5/2024 | $0 |
| | 2024 | 2020 | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, THE | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | U19AI144306 | Etiology and outcome of MIS-C | 001 | 2 | NIH | 1/26/2024 | $0 |
|
